Categories:

• Agriculture and Forestry
• Automotive
• Biotechnology and Pharmaceuticals
• Chemicals
• Construction and Maintenance
• Consumer Goods and Services
• Electronics and Electrical
• Energy and Environment
• Food and Related Products
• Industrial Goods and Services
• Information Technology
• Materials
• Real Estate
• Telecommunications
• Textiles and Nonwovens
• Transportation and Logistics

Popular Tags:

• player
• mp4
• mp4 player
• screen
• player screen
• screen mp4
• 4gb
• player 4gb
• 4gb mp4
• card
• slot
• player card
• 18inch
• inch
• 15inch
• inch mp4
• inch player
• flash
• style
• builtin

Home › Alnylam Presents New Pre-Clinical Data On RNAi Therapeutics Targeting Transthyretin (TTR) For The Treatment Of TTR-Mediated Amyloidosis (ATTR)

 

Alnylam Presents New Pre-Clinical Data On RNAi Therapeutics Targeting Transthyretin (TTR) For The Treatment Of TTR-Mediated Amyloidosis (ATTR)

2014-04-30 06:24:19| drugdiscoveryonline News Articles

Alnylam Pharmaceuticals, Inc. a leading RNAi therapeutics company, recently announced the presentation of new pre-clinical data on RNAi therapeutics targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis (ATTR)

Tags: data treatment presents targeting

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»

04.07 EU hits Chinese electric cars with steep tariffs 04.07 Hurricane Beryl Forecast Discussion Number 23 04.07 Hurricane Beryl Public Advisory Number 23 04.07 Summary for Hurricane Beryl (AT2/AL022024) 04.07 Hurricane Beryl Wind Speed Probabilities Number 23 04.07 Hurricane Beryl Forecast Advisory Number 23 04.07 Atlantic Tropical Weather Outlook 04.07 Eastern North Pacific Tropical Weather Outlook More »